APEX1 and cancer: In EAC, significant expression of APE1 (apurinic/apyrimidinic endonuclease 1) has been shown to regulate MMP‐14, activating MMP‐2 and leading to redox‐dependent ECM degradation, thus affecting the invasive capacity of cancer cells.96